{
    "code": "06021398",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06021398",
    "time": "2022-04-08 06:19:37",
    "許可證字號": "衛署醫器輸字第021398號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD10814",
    "有效日期": "114\/08\/11",
    "發證\/登錄日期": "99\/08\/11",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00602139806",
    "中文品名": "亞培設計師肌酸激酶之MB同功異構酶試劑組-品管液",
    "英文品名": "ABBOTT ARCHITECT STAT CK-MB Controls",
    "效能": "ARCHITECT STAT CK-MB對照劑是用於定量測試人類血清或血漿中之肌酸激&#37238;之MB同功&#37238;時，作為確認具STAT程序效能之ARCHITECT i系統之準確度及精密度。",
    "醫器規格": "2K42-10\r\n\r\n規格 (目標濃度及範圍變更)及仿單標籤變更為：詳如中文仿單核定本。(原102年5月23日仿單標籤核定本正本收回作廢)。以下空白。\r\n\r\n規格及仿單標籤變更為：詳如中文仿單核定本。(原108年12月6日仿單標籤核定本正本收回作廢)。以下空白。\r\n醫療器材規格與標籤、說明書或包裝變更為：詳如醫療器材標籤、說明書或包裝核定本(原109年3月2日醫療器材仿單標籤核定本回收作廢)。以下空白",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1660品管材料(分析與非分析)",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "0932301100  美商亞培股份有限公司台灣分公司",
    "申請商地址": "台北市中山區民生東路三段49號5樓、6樓及51號6樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "MUS1106200  ABBOTT LABORATORIES",
            "製造廠廠址": "100 ABBOTT PARK ROAD, ABBOTT PARK, ILLINOIS 60064, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "06021398-111-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06021398&Seq=007&Type=9"
        },
        {
            "title": "06021398-111-02-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06021398&Seq=008&Type=8"
        }
    ]
}